Stock listing
Frankfurt:G49N Gensight Biologics SA Aktie
German listing (Frankfurt) of Gensight Biologics SA · home listing Euronext:SIGHT
Follow Gensight Biologics SA into a list and get an email when it puts out news.
Share price · FWB:G49N
€0.067 EUR +0.001 (+2.0%)
Close on Oct 30, 2026
- Day range
- €0.067 – €0.067 EUROct 30, 2026
- Market cap
- €16.51M EURAt the close on Oct 30, 2026 · price × 245.3M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:SIGHT · Home | €0.072 EUR | -0.002 (-2.1%) | 721,202 | €0.073 | €0.073 | €0.071 | €0.073 | Close on Nov 3, 2026 |
| LSE:0RIM | €0.072 EUR | 0.000 (-0.1%) | 2,344 | €0.072 | €0.072 | €0.072 | €0.072 | Close on Oct 27, 2026 |
| Frankfurt:G49N | €0.067 EUR | +0.001 (+2.0%) | — | €0.067 | €0.067 | €0.067 | €0.066 | Close on Oct 30, 2026 |
- Ticker
- Frankfurt:G49N
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 16, 2026
GenSight Biologics Announces the Closing of its €1.0 Million Fundraising Supported by Existing Shareholders
Latest deck · May 19, 2026
Shareholder Meeting (May 2026)
Shareholder meeting · 59 slides
Latest news
Financings
Private placement of ordinary shares, pre-funded warrants and investor warrants
Oct 16, 2026
Closed: €1M in the latest tranche · €0.077 a share · Warrants at €0.0497 for 60 months
Buyers: Heights Capital; Invus
Use of proceeds: Operating activities and working capital pending the structural financing of the RECOVER Phase III trial
Decks
Shareholder Meeting (May 2026)
Shareholder meeting · 59 slides · May 19, 2026
Investor Presentation (October 2025)
Investor deck · 26 slides · October 2025
Investor Presentation (May 2025)
Investor deck · 26 slides · May 2025
Investor Presentation (September 2024)
Investor deck · 22 slides · September 2024
Gensight Biologics SA on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 35 in the last 12 months · 48 in all · newest Oct 16, 2026 · oldest 2025
- Decks
- 15 decks · latest May 19, 2026
Where Gensight Biologics SA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:SIGHT · Home listing | Euronext | France | EUR |
| LSE:0RIM | LSE | United Kingdom | EUR |
| gettex:G49N | gettex | Germany | EUR |
| LS Exchange:A2ANGZ | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2ANGZ | Lang & Schwarz | Germany | EUR |
| Aquis:SIGHTP | Aquis | United Kingdom | EUR |
| OTC:GSGTF | OTC | United States | USD |
| Aquis:SIGHTP | Aquis | United Kingdom | EUR |
| Dusseldorf:G49N | Dusseldorf | Germany | EUR |
| Frankfurt:G49N · This page | Frankfurt | Germany | EUR |
| Hamburg:G49N | Hamburg | Germany | EUR |
| Munich:G49N | Munich | Germany | EUR |
| Stuttgart:G49N | Stuttgart | Germany | EUR |
| Turquoise:SIGHTP | Turquoise | United Kingdom | EUR |
Log in to ask 6ix AI your own questions about Gensight Biologics SA.